SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
Data Shows: Demand Surges in Asia; Informatics Leveraging Two Decades of Training Experience to Help Over 10,000 People Join Professional Ranks HONG KONG,...
BEIJING, Dec. 17, 2025 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") (Nasdaq: UXIN), China's leading used car retailer, today announced the official opening...
Driving Diversity and Inclusion Workplace Through the 3H Strategy: Happy, Healthy, Hearty TAIPEI, Dec. 16, 2025 /PRNewswire/ -- Cathay United Bank (CUB) has...
BEIJING, Dec. 17, 2025 /PRNewswire/ -- Once hailed by Marco Polo as a "great eastern port" teeming with merchants and goods, Quanzhou, a world heritage...
BEIJING, Dec. 17, 2025 /PRNewswire/ -- A wine-themed folk culture festival kicked off in Mengshan Town in east China's Jiangxi Province on Dec. 4, offering...
